Workflow
今日1新股申购!格力、美的“小伙伴”将登陆北交所
Zheng Quan Shi Bao·2025-09-22 01:12

Group 1: New IPOs and Offerings - This week, there is one new stock available for subscription, specifically the new stock from Aomeisen, which will start subscription on September 22 [2][9] - Aomeisen's offering price is set at 8.25 yuan per share, with an issuance price-to-earnings ratio of 12.99 times, compared to the industry average dynamic price-to-earnings ratio of 35.86 times over the past month [2][3] Group 2: Company Overview - Aomeisen is a professional manufacturer of intelligent equipment, focusing on the research, design, production, and sales of intelligent production equipment and production lines [2][9] - The company's products are widely applicable in various sectors, including electrical appliances, environmental protection, wind power, and lithium battery new energy [2] - Aomeisen has established stable partnerships with major domestic and international home appliance companies, enhancing its brand influence and market presence [2] Group 3: Financial Performance - Aomeisen's projected revenues for 2022, 2023, and 2024 are 279 million yuan, 325 million yuan, and 358 million yuan, respectively, with net profits of approximately 19.39 million yuan, 48.16 million yuan, and 55.82 million yuan [3] - The company aims to raise a total of 190 million yuan through its IPO, which will be invested in the construction of a production base for digital forming equipment and a research and development center [3] Group 4: Other IPOs - Four companies are scheduled for IPO meetings this week, including Moer Thread and Bai Ao Sai Tu for the Sci-Tech Innovation Board, and Nanguang Digital and Hengtong Light for the Growth Enterprise Market [4] - Moer Thread focuses on the research, design, and sales of GPUs and related products, aiming to provide computing acceleration platforms for high-performance computing fields [5] - Bai Ao Sai Tu, a preclinical CRO and biotechnology company, offers innovative animal models and drug development services based on its gene editing technology [7][8]